###begin article-title 0
Incorporating prior knowledge to facilitate discoveries in a genome-wide association study on age-related macular degeneration
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
Substantial genotyping data produced by current high-throughput technologies have brought opportunities and difficulties. With the number of single-nucleotide polymorphisms (SNPs) going into millions comes the harsh challenge of multiple-testing adjustment. However, even with the false discovery rate (FDR) control approach, a genome-wide association study (GWAS) may still fall short of discovering any true positive gene, particularly when it has a relatively small sample size.
###end p 2
###begin title 3
Findings
###end title 3
###begin p 4
###xml 509 512 509 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFHR4</italic>
###xml 525 529 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SGCD</italic>
To counteract such a harsh multiple-testing penalty, in this report, we incorporate findings from previous linkage and association studies to re-analyze a GWAS on age-related macular degeneration. While previous Bonferroni correction and the traditional FDR approach detected only one significant SNP (rs380390), here we have been able to detect seven significant SNPs with an easy-to-implement prioritized subset analysis (PSA) with the overall FDR controlled at 0.05. These include SNPs within three genes: CFH, CFHR4, and SGCD.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
Based on the success of this example, we advocate using the simple method of PSA to facilitate discoveries in future GWASs.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 704 705 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
Substantial genotyping data produced by current high-throughput technologies have brought opportunities and difficulties. High-density genotyping platforms have been developed in a hope that underlying disease-associated genes can be identified through denser and denser collections of single-nucleotide polymorphism (SNP) data. However with the number of SNPs going into millions comes the harsh challenge of multiple-testing adjustment. To counteract multiple-testing penalty incurred by testing such a large number of SNPs, some genome-wide association studies (GWASs) responded by taking a large sample size--with the number of study subjects soaring into thousands, tens of thousands, or even more [1].
###end p 8
###begin p 9
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 397 398 397 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 519 520 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 994 996 994 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
There are two approaches for multiple-testing adjustments. One is controlling the family-wise error rate (FWER), the other is controlling the false discovery rate (FDR) [2,3]. The FWER is defined as the probability of at least one type I error. Among methods for controlling FWER, the Bonferroni correction is the best known approach, although it is very conservative. Holm's step-down procedure [4] is less conservative than the classical Bonferroni correction. The FWER can also be controlled by the resampling-based P-value adjustment procedure. Compared with controlling the FWER, controlling the FDR is usually a more powerful approach. However, even with the FDR approach, a GWAS may still fall short of discovering any true positive gene, particularly when it has a relatively small sample size. When testing simultaneously for a huge number of SNPs, even true positive SNPs would have difficulty in standing out among all the noise, based on a straight (and brutal) comparison of their p values. GWAS on age-related macular degeneration (AMD) is a good example, and we will show this in this paper.
###end p 9
###begin p 10
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 608 609 608 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
The above simple FDR approach has been further extended to dependent tests and to tests with prior information [5]. The false discovery control with P-value weighting [5,6] can improve power when the assignment of weights (based on previous linkage evidence [6]) is adequate, but there is some power loss when the weights are poorly assigned. Sun et al.'s [7] stratified false discovery control is another approach. They partitioned all SNPs into two subsets based on minor-allele frequencies (MAFs), and then the FDR control is applied to the two subsets respectively. However, as pointed out by Li et al. [8], MAFs have little relevance with biological information and thus partitioning SNPs based on MAFs probably may not improve much power. To address this issue, Li et al. [8] proposed a 'prioritized subset analysis' (PSA). The PSA makes clever use of available prior knowledge, either of the linkage information, the biological information or both. We will show that the PSA can greatly facilitate discoveries in GWASs, with a demonstration on an AMD data.
###end p 10
###begin title 11
Methods
###end title 11
###begin title 12
Materials: a GWAS on Age-related Macular Degeneration (AMD)
###end title 12
###begin p 13
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 327 329 325 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 389 390 385 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
AMD is a genetically complex disorder. The heritability was estimated to range from 46% to 71%. Klein et al. [9] reported an AMD data set containing 96 AMD cases and 50 controls. Of all the 116,204 genotyped SNPs, 99,317 SNPs were informative (MAF >/= 1%) and conformed to Hardy-Weinberg equilibrium (with Hardy-Weinberg exact p value >/= 0.05 in the 50 controls). Following Klein et al. [9], we test for allelic association with disease status on each SNP.
###end p 13
###begin title 14
Prioritized Subset Analysis
###end title 14
###begin p 15
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
To facilitate discoveries in GWASs, we turned to a new method of 'prioritized subset analysis' (PSA) [8]. To perform a PSA, a researcher based on his/her prior biological knowledge first picks from among all SNPs under study, a certain number of SNPs likely to be the true positives. He/she then places those selected SNPs in a 'prioritized subset' and those remaining in a 'non-prioritized' subset. The FDR control is then applied to these two subsets separately, and the significant results are harvested from both the two subsets.
###end p 15
###begin title 16
Prioritizing SNPs
###end title 16
###begin p 17
We took findings from previous genome-wide linkage and association studies on AMD as our prior knowledge to prioritize SNPs. Our prioritization process is detailed below.
###end p 17
###begin p 18
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
We first incorporated evidence of linkage (with LOD score >2.0) based on previous linkage studies [10-16]. We obtained the physical position of each D-number marker (listed in Table 1) from the Gene Location website . Then SNPs within 500 kb from each D-number marker were prioritized.
###end p 18
###begin p 19
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 193 196 193 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 485 486 485 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 510 519 510 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 520 526 520 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1 </italic>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 684 687 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFB</italic>
###xml 742 744 742 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C2</italic>
###xml 836 840 836 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH </italic>
###xml 841 843 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 918 920 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1003 1007 1003 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH </italic>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1094 1096 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1097 1099 1097 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1155 1159 1155 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH </italic>
###xml 1200 1201 1200 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 1315 1319 1315 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH </italic>
###xml 1444 1446 1444 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
Moreover, several genes have had at least one positive association finding [17,18]. These genes with SNPs genotyped in the AMD data set are listed in Table 1. For example, complement factor H (CFH, GeneID 3075) gene within 1q32 was reported to be related to AMD, both from genome-wide linkage analyses [10-15] (all published before Klein et al. [9]) and case-control studies [19-21] (all independent of Klein et al.'s study [9], and published at the same year of Klein et al.'s paper [9]). We also learnt that LOC387715/HTRA1 (GeneID 5654) locus within 10q26 was identified as a second major locus contributing to AMD pathogenesis [22,23]. Furthermore, complement component factor B (CFB, GeneID 629) and the adjacent complement component 2 (C2, GeneID 717) on chromosome 6p21, were reported to act along the same biological pathway as CFH [24,25]. When prioritizing SNPs, we used the Bioinformatics tool 'GenoWatch' [26] to identify SNPs around these candidate genes. The chromosomal region around the CFH gene had been shown by several independent studies to be linked [10-15] or associated [19-21] with AMD, so we prioritized SNPs within 1 Mb from the CFH gene. For other candidate genes in Table 1, we prioritized SNPs within 50 kb from each. (For example, to check whether SNP rs800292 is within 1 Mb from the CFH gene, we simply insert 'rs800292' into 'SNP ID' and '1 Mb' into the 'Upstream' and 'Downstream' on the website of GenoWatch [26]: )
###end p 19
###begin p 20
Genes or markers to be prioritized, in the prioritized subset analysis
###end p 20
###begin p 21
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
In the end, a total of 639 SNPs were prioritized, and the remaining 98,678 SNPs, non-prioritized. We then applied the PSA with the FDR being controlled at 0.05, for both the prioritized subset and the non-prioritized subset. We used Storey and Tibshirani's [3] smoothing spline approach provided by the package 'fdrtool' [27] to estimate the proportions of true negative SNPs.
###end p 21
###begin title 22
Results
###end title 22
###begin title 23
Bonferroni Correction and Traditional FDR Approach
###end title 23
###begin p 24
###xml 105 108 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7 </sup>
###xml 207 211 207 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH </italic>
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 514 515 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
Controlling the FWER at 0.05 (the level of significance for each SNP being set at 0.05/99,317 = 5.03 x 10-7 with the Bonferroni correction), only one significant SNP (rs380390) can be identified (within the CFH gene, see Table 2). (Klein et al. [9] actually found one additional significant SNP, rs10272438, but it was later dropped because of low call rate and possible genotyping errors.) Controlling the FDR at 0.05 wasn't any better--the same (and the only one) SNP rs380390 was found to be significant (Table 2). Note that this SNP, rs380390, though being significant, was still not 100% guaranteed to be a true positive (because it was detected under a FDR control value of 0.05).
###end p 24
###begin p 25
Results of the AMD data set
###end p 25
###begin p 26
###xml 2 4 2 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
* P values were obtained from Fisher's exact test for allelic association with disease status.
###end p 26
###begin p 27
** S: significant; NS: not significant
###end p 27
###begin title 28
Prioritized Subset Analysis
###end title 28
###begin p 29
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 137 140 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFHR4</italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SGCD</italic>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH </italic>
###xml 442 447 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFHR4</italic>
###xml 580 585 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SGCD </italic>
###xml 709 714 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SGCD </italic>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 799 804 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SGCD </italic>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
###xml 826 832 <span type="species:ncbi:9606">humans</span>
The PSA identified a total of seven significant SNPs (all from the prioritized subset) (Table 2). These include SNPs within three genes: CFH, CFHR4, and SGCD. By using the PSA method, we have been able to detect six additional significant SNPs (in two additional genes), compared to the Bonferroni approach (the method used by Klein et al. [9]) or the traditional FDR approach. Two of the three significant genes found in this study, CFH and CFHR4, are located in a chromosomal region (1q31-1q32) having been most replicated in previous AMD studies. The remaining one significant SGCD gene had not been previously reported to be AMD-related, though. However, we notice that previous animal studies showed the SGCD gene is related to vascular abnormalities in mice [28]. This might suggest a link of SGCD to neovascular AMD in humans.
###end p 29
###begin p 30
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 256 258 256 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 276 277 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 291 292 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 308 310 308 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i </italic>
###xml 332 334 332 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B </italic>
###xml 379 381 379 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FP</italic>
###xml 407 409 407 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d </italic>
###xml 420 423 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-4 </sup>
###xml 438 440 438 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 487 488 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 499 501 499 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B </italic>
All the seven significant SNPs are from the prioritized subset. To evaluate how well the FDR is controlled in our prioritized subset, we further estimated the permutation-based FDR [29] in this subset. We randomly permuted the data and calculated the null P values -  for the ith SNP in the bth permutation (i = 1,...,639). Through B permutations, the number of false positives (FP) is estimated as , where d = 5.12 x 10-4 is the largest P value of the seven significant SNPs (see Table 2). We took B = 100,000 and obtained  = 0.225. The permutation-based FDR in the prioritized subset is thus estimated as 0.225/7 = 0.032, which is still less than our FDR control level of 0.05, suggesting a satisfactory FDR control in this subset.
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 265 267 265 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 443 450 443 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">before </italic>
###xml 651 652 651 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 734 743 734 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">previous </italic>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
Prior information can come from a researcher's biological knowledge, or findings of data other than that provided in the current study. But one should not 'snoop' his/her data at hand for the prior knowledge. If one naively prioritizes those SNPs with the smallest p values in the study data, the actual overall FDR would no longer be properly controlled. To avoid such bias, we searched findings of other data to build our 'prior knowledge', before seeing the analysis results of individual SNPs in the current AMD data set. At that time, we did know that rs380390 is a significant SNP in the AMD data set which can withstand a FWER control of 0.05 [9]. But the chromosomal region around rs380390 had already been replicated by many previous linkage studies [10-15] (all published before Klein et al. [9]). And so, prioritizing chromosomal region around rs380390 won't constitute an act of data snooping.
###end p 32
###begin p 33
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH </italic>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH </italic>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
Around a particular gene, how large a chromosomal region should be prioritized is also an issue. Because of the consistent findings in the CFH gene, both from genome-wide linkage analyses [10-15] and case-control studies [19-21], we prioritized SNPs within 1 Mb from the CFH gene. Other evidence of linkage and associations are relatively unconfirmed by prior studies, so we prioritized SNPs within 500 kb and 50 kb, respectively. Because linkage is a coarse mapping whereas association is a fine mapping, in general a wider region of SNPs should be prioritized for a linkage peak. Admittedly, there is no absolute criterion for choosing the sizes of prioritized regions. No matter how large a chromosomal region is prioritized, the FDR within subsets should be controlled at the desired level, and this can be verified by estimating the permutation-based FDR [29].
###end p 33
###begin p 34
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
In recent GWASs, a commonly used approach to incorporate prior knowledge is to calculate the Bayes factors [1,30]. However, to estimate the Bayes factors, the prior distributions and the effect sizes should be carefully specified [30]. This may limit its applicability. By contrast, the PSA method used in this paper can feed on prior knowledge that is only rudimentary (we need only to decide beforehand whether a particular SNP is more likely a true positive or a true negative, but don't need to know exactly how likely). And there is almost no penalty for poor guessing [8]. In this paper, we demonstrated that such a simple dichotomization followed by a simple PSA can greatly facilitate discoveries in a GWAS on AMD.
###end p 34
###begin p 35
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
Note that we did not recruit any more subjects or type any more SNPs beyond what Klein et al. [9] had done. The only thing we did is to incorporate prior knowledge about AMD into the analysis. And we see this input of knowledge is rather powerful (six/two additional significant SNPs/genes were identified in the same AMD case-control data). One may question that our input of knowledge and the subsequent partition of SNPs into two subsets to be tested separately and harvested combinedly are making easier (and perhaps too easier) for the SNPs to come out. But we should emphasize that we did not loosen our FDR control in any way. The total seven significant SNPs found in this re-analysis have an overall 0.05 FDR attached to them, much the same way with the one SNP rs380390 originally found in Klein et al. [9] had a 0.05 FDR attached to it. And we believe that researchers will find no difficulties to choose seven SNPs or just one--that is, under the same FDR criteria.
###end p 35
###begin title 36
Conclusions
###end title 36
###begin p 37
The PSA approach is rather powerful and is easy to implement. Based on the success of our re-analysis of Klein et al's GWAS on AMD, we advocate using PSA to facilitate discoveries in future GWASs.
###end p 37
###begin title 38
Competing interests
###end title 38
###begin p 39
The authors declare that they have no competing interests.
###end p 39
###begin title 40
Authors' contributions
###end title 40
###begin p 41
W-Y L participated in the design of the study, performed the data analyses, and drafted the manuscript. W-C L conceptualized the study, provided advice, and revised the manuscript. All authors read and approved the final manuscript.
###end p 41
###begin title 42
Acknowledgements
###end title 42
###begin p 43
We would like to thank the anonymous reviewers for their constructive comments. We also thank Dr. Josephine Hoh for kindly providing the AMD data set. This study was supported by National Science Councils, Taiwan.
###end p 43
###begin article-title 44
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
###end article-title 44
###begin article-title 45
Controlling the false discovery rate: A practical and powerful approach to multiple testing
###end article-title 45
###begin article-title 46
Statistical significance for genomewide studies
###end article-title 46
###begin article-title 47
A simple sequentially rejective multiple test procedure
###end article-title 47
###begin article-title 48
False discovery control with P-value weighting
###end article-title 48
###begin article-title 49
Using linkage genome scans to improve power of association in genome scans
###end article-title 49
###begin article-title 50
Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies
###end article-title 50
###begin article-title 51
Prioritized subset analysis: improving power in genome-wide association studies
###end article-title 51
###begin article-title 52
Complement factor H polymorphism in age-related macular degeneration
###end article-title 52
###begin article-title 53
Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease
###end article-title 53
###begin article-title 54
Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration
###end article-title 54
###begin article-title 55
Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q
###end article-title 55
###begin article-title 56
Age-related macular degeneration--a genome scan in extended families
###end article-title 56
###begin article-title 57
A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions
###end article-title 57
###begin article-title 58
Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions
###end article-title 58
###begin article-title 59
Genome-wide analyses demonstrate novel loci that predispose to drusen formation
###end article-title 59
###begin article-title 60
An update on the genetics of age-related macular degeneration
###end article-title 60
###begin article-title 61
The genetics of age-related macular degeneration: a review of progress to date
###end article-title 61
###begin article-title 62
Complement factor H polymorphism and age-related macular degeneration
###end article-title 62
###begin article-title 63
Complement factor H variant increases the risk of age-related macular degeneration
###end article-title 63
###begin article-title 64
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration
###end article-title 64
###begin article-title 65
Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk
###end article-title 65
###begin article-title 66
Susceptibility genes for age-related maculopathy on chromosome 10q26
###end article-title 66
###begin article-title 67
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
###end article-title 67
###begin article-title 68
C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes
###end article-title 68
###begin article-title 69
GenoWatch: a disease gene mining browser for association study
###end article-title 69
###begin article-title 70
A unified approach to false discovery rate estimation
###end article-title 70
###begin article-title 71
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Altered biomechanical properties of carotid arteries in two mouse models of muscular dystrophy
###end article-title 71
###begin article-title 72
A note on using permutation-based false discovery rate estimates to compare different analysis methods for microarray data
###end article-title 72
###begin article-title 73
Reporting and interpretation in genome-wide association studies
###end article-title 73

